Feb 28, 2022 / 01:00PM GMT
Operator
Good morning, and welcome to Mersana Therapeutics' Fourth Quarter and Year-End 2021 Conference Call and Webcast. (Operator Instructions).
I would now like to turn the call over to James Salierno, Associate Director, Investor Relations. Please proceed.
James Salierno - Mersana Therapeutics, Inc. - Associate Director of IR
Good morning. Welcome to Mersana's Fourth Quarter and Year-End 2021 Conference Call. Earlier today, we issued a press release reviewing our fourth quarter and full year financial results and business updates, which will be covered on this call. A replay of today's call will also be available on the Investors and Media section of our website. After our prepared remarks, we will open up the call for Q&A.
Before we begin, I'd like to mention that our call will contain forward-looking statements within the meaning of federal securities laws, including with respect to the company's business strategy and the design, progression and timing of its clinical trials or preclinical studies and the release of data from those studies;
Q4 2021 Mersana Therapeutics Inc Earnings Call Transcript
Feb 08, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers